These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 5300097)
21. Management of drug failure cases. Dingley HB Bull Int Union Tuberc; 1972 Aug; 47 Suppl 2():76-89. PubMed ID: 4145683 [No Abstract] [Full Text] [Related]
22. Clinical experience with ethambutol. Wilson TM Antibiot Chemother; 1970; 16():222-9. PubMed ID: 4108890 [No Abstract] [Full Text] [Related]
23. General considerations in intermittent drug therapy of pulmonary tuberculosis. Fox W Postgrad Med J; 1971 Nov; 47(553):729-36. PubMed ID: 4110537 [TBL] [Abstract][Full Text] [Related]
24. [Treatment with secondary antitubercular agents]. Ovreberg K Tidsskr Nor Laegeforen; 1968 May; 88(9):741-9. PubMed ID: 4298856 [No Abstract] [Full Text] [Related]
25. A ten-year clinical experience with Mycobacterium kansasii. Rauscher CR; Kerby G; Ruth WE Chest; 1974 Jul; 66(1):17-9. PubMed ID: 4846114 [No Abstract] [Full Text] [Related]
31. Treatment of tuberculosis today in Nebraska. Burgher LW; Kass I Nebr Med J; 1973 May; 58(5):156-62. PubMed ID: 4348990 [No Abstract] [Full Text] [Related]
32. Chronic tuberculosis in refractory patients--therapeutic aspects. Foster-Carter AF Respiration; 1969; 26():Suppl:76-81. PubMed ID: 5381385 [No Abstract] [Full Text] [Related]
33. New antituberculosis drugs and concepts of prophylaxis. Wolinsky E Med Clin North Am; 1974 May; 58(3):697-704. PubMed ID: 4362723 [No Abstract] [Full Text] [Related]
34. Ethambytol in the retreatment of pulmonary tuberculosis. United States Public Health Service cooperative trial. Steininger WJ Bull Int Union Tuberc; 1968 Dec; 41():181-2. PubMed ID: 4303861 [No Abstract] [Full Text] [Related]
35. The problem of the chronic excretor of tubercle bacilli. Stýblo K; Kubík A; Langerová M; Matusková E; Morávková K Scand J Respir Dis; 1968; 49(3):236-48. PubMed ID: 4309247 [No Abstract] [Full Text] [Related]
36. Experimental "in vivo" studies of new antituberculosis drugs: capreomycin, ethambutol, rifampicin. Grumbach F Tubercle; 1969 Mar; 50():Suppl:12-21. PubMed ID: 5402543 [No Abstract] [Full Text] [Related]
37. Studies on atypical mycobacteria. X. Experimental approach to the etiology of atypical mycobacteriosis. Ogawa T; Motomura K Kekkaku; 1971 Sep; 46(9):365-70. PubMed ID: 5122006 [No Abstract] [Full Text] [Related]
38. A comparison of regimens of ethionamide, pyrazinamide and cycloserine in re-treatment of patients with pulmonary tuberculosis. Bignall JR Bull Int Union Tuberc; 1968 Dec; 41():175-7. PubMed ID: 4885379 [No Abstract] [Full Text] [Related]
39. The treatment of tuberculosis. Springett VH Practitioner; 1975 Oct; 215(1288):480-6. PubMed ID: 53832 [No Abstract] [Full Text] [Related]
40. [Experimental chemotherapy of tuberculosis]. Krebs A Z Erkr Atmungsorgane Folia Bronchol; 1969; 130(5):417-48. PubMed ID: 4899157 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]